• Flag United States US
  • Flag Australia AU
  • Flag Canada CA
  • Flag EUR EUR
  • Flag China CN
  • Flag Germany DE
  • Flag New Zealand NZ
  • Flag United Kingdom UK
  • Flag Ireland IE
  • Flag Mexico MX
  • Flag United Nations Global
  • All
mobile menu
business
COMPANY BENCHMARKING • UNITED STATES

Zoetis Inc. - Company Profile

Access all 5,000+ company profiles through the Benchmarking Pro Membership. Unlock interactive competitor comparison tools that show you how Zoetis Inc. stacks up to the competition and put relevant competitor and industry information at your fingertips.


Zoetis Inc. - Overview

Brands
AlphaTRAK, Apoquel, Bovi-Shield, Clarifide, Clavamox, Convenia, CORE EQ Innovator, Cytopoint, Dectomax, Dexdomitor, Draxxin, Excede, Inforce, Palladia, Quest, Simbadol, Vanguard, VetScan, West Nile Innovator, Witness
Description
Zoetis is a public company headquartered in New Jersey with an estimated 13,800 employees. In the US, the company has a notable market share in at least one industry: Animal Health Biotechnology, where they account for an estimated 35.5% of total industry revenue and are considered an All Star because they display stronger market share, profit and revenue growth compared to their peers.
Company Details

Registered Name: Zoetis Inc.

Company Type: Operating

Exchange: NYSE

Headquarters: 10 Sylvan Way, NJ 07054

Website: http://www.zoetis.com

Employees: 13800

Zoetis Inc. - Operating Industries and Main Competitors

error_outline To view all of Zoetis Inc.'s operating industries and competitors, see purchase options.

Zoetis Inc. - Products and Services

  • Animal Health Biotechnology

    • Of the 4 core revenue-generating products and services in the Animal Health Biotechnology industry, Zoetis Inc. offers:
    • Anti-infectives
    • Medications and vaccines
    • Other
error_outline To view Zoetis Inc.'s full products and services, see purchase options.

Zoetis Inc. - SWOT Analysis

Strengths and weaknesses take into account internal factors, and are based on Zoetis Inc.'s performance in comparison to its competitors. Opportunities and Threats focus on external influences, and are based on trends and demand in the Animal Health Biotechnology industry.
Strengths
Days Receivables: x.x%
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Annual Turnover: x.x%
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Weaknesses
Credit Risk: x.x%
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Revenue per Employee: $xx
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Opportunities
  • AAAAA
  • AAAAA
  • AAAAA
Threats
  • AAAAA
  • AAAAA
  • AAAAA

error_outline To view Zoetis Inc.'s full SWOT analysis, see purchase options.

Zoetis Inc. - Financial Statements & Ratios

pie_chartZoetis Inc. Income Statement

BALANCE DATE12/31/201812/31/201912/31/202012/31/202112/31/202212/31/2023
Revenue5,825.06,260.06,675.07,776.08,080.08,544.0
Cost of Revenue000000000000000000000000
Cost of Revenue, Non-Cash000000000000000000000000
Gross Profit000000000000000000000000
Other000000000000000000000000

pie_chartZoetis Inc. Balance Sheet

BALANCE DATE12/31/201812/31/201912/31/202012/31/202112/31/202212/31/2023
Cash and Equivalents1,602.01,934.03,604.0N/AN/AN/A
Short-Term Investments000000000000000000000000
Derivative Assets, Current000000000000000000000000
Restricted Cash and Investments000000000000000000000000
Other000000000000000000000000

pie_chartZoetis Inc. Cash Flow

BALANCE DATE12/31/201812/31/201912/31/202012/31/202112/31/202212/31/2023
Net Income1,424.01,500.01,636.02,034.02,111.02,340.0
Income (Loss) From Discontinued Operations000000000000000000000000
Depreciation, Depletion and Amortization000000000000000000000000
Amortization of Financing Costs and Discounts000000000000000000000000
Other000000000000000000000000

error_outline To view all financial data for Zoetis Inc., see purchase options.

GET INSTANT ACCESS WITH BENCHMARKING PRO MEMBERSHIP

100% Money Back Guarantee Digicert Trusted

BENCHMARKING PRO

What's Inside
Benchmarking Pro?

A suite of company and industry data that:

Benchmarks companies against industry averages or like-sized segments, as well as close competitors
Identifies real-world strengths, opportunites, weaknesses and threats
Reveals growth opportunities or red flags in a business growth strategy
LEARN MORE

Included in Report

  • Enterprise History & Synopsis
    Enterprise History & Synopsis
  • Enterprise Financial Statements
    Company Financial Statements
  • Financial Ratios
    Industry Market Share Breakdown
  • Industry Averages
    Industry Competitor Matrix
  • Competitive Landscape
    SWOT Analysis
  • Key Enterprise Personnel
    Products and Services
  • Subsidiaries & Ownership Structure
    Key Company Benchmarks

Why purchase access to Benchmarking Pro?

This profile on Zoetis Inc. includes:

  • Company Overview
  • Company Revenue and Employee Data
  • Company Financial Statements
  • Industry Market Share Breakdown
  • Industry Competitor Matrix
  • SWOT Analysis
  • Products and Services
  • Key Company Benchmarks
  • Interconnected Competitor Profiles and Industry Reports
  • Full Access to Benchmarking Pro

The IBISWorld Benchmarking Pro solution enables you to:

  • Understand an enterprise’s competitive landscape and how they perform within a like-sized industry segment.
  • Benchmark companies against industry averages, segment averages and their competitors.
  • Identify real-world strengths, opportunities, weaknesses and threats for companies.
  • Target growth opportunities or spot red flags in a business growth strategy.
  • Toggle between company profiles and industry reports for a 360 degree view of a company's position.

IBISWorld provides profiles on thousands of leading companies around the world. Our clients rely on our information and data to stay up-to-date on business and industry trends across all sectors of the economy. This company profile, along with the corresponding competitor and industry data provided, includes thoroughly researched, reliable and current information that will help you to make faster, better business decisions.

Trusted by More Than 10,000 Clients Around the World

  • IBISWorld client - VISA
  • IBISWorld client - ADP
  • IBISWorld client - Deloitte
  • IBISWorld client - AMEX
  • IBISWorld client - Bank of Montreal